Source-backed quick answer
Addiction medicine billing service checks
Addiction medicine billing services should verify patient eligibility, OUD treatment documentation, E/M or procedure coding, ICD-10 support, authorization, payer-specific behavioral health rules, EOB or ERA denial detail, and appeal timing before resubmission.
CMS OUD treatment, PFS, ICD-10, and electronic billing resources support service coverage, code validation, diagnosis support, and claim workflow controls for addiction medicine practices.
- OUD and behavioral health service review
- E/M and procedure code validation
- Authorization and payer rule checks
- Denial tracking and appeal packet support
Official sources
Addiction Medicine Medical Billing Overview
A patient came in six months ago barely able to hold a conversation. He was in opioid withdrawal, his Medicaid managed care card was expired, and the intake coordinator spent 45 minutes sorting out his coverage before the physician could even begin the buprenorphine induction. Today, he shows up on time, employed again, and asking about getting his driver’s license reinstated. The clinical story is a success. The billing story is messier: those six months generated a complex mix of office visits, medication management codes, urine drug screen interpretations, and psychiatric consultation codes billed across a Medicaid plan, a brief period of uninsured status, and now a new commercial plan through his employer. If the practice does not have a billing operation sophisticated enough to handle that kind of payer transition and code complexity, a meaningful portion of that care never gets paid.
Addiction medicine billing has expanded significantly since the passage of the Drug Addiction Treatment Act of 2000 (DATA 2000) and subsequent updates through the SUPPORT for Patients and Communities Act. Office-based opioid treatment (OBOT) programs billing buprenorphine-based medication-assisted treatment generate recurring monthly revenue through monthly medication management visits, periodic urine drug screen panels, and behavioral health co-management codes. Alcohol use disorder treatment adds another billing layer, including naltrexone management visits and alcohol biomarker testing. The Mental Health Parity and Addiction Equity Act creates legal obligations for payers including UnitedHealthcare, BCBS, Aetna, and Cigna to cover addiction medicine services at parity with medical and surgical benefits, which strengthens the billing environment but also requires active monitoring of payer compliance.
Common Billing Challenges in Addiction Medicine
- UDS interpretation billing complexity: Urine drug screen billing has two tiers: presumptive qualitative screens (CPT 80305, 80306, 80307) and definitive quantitative testing (G0480 through G0483 for Medicare). Billing the definitive panel code when only a presumptive screen was performed, or vice versa, creates denial and audit exposure. Medicare specifically restricts the frequency of definitive UDS testing, and billing above those limits requires advance beneficiary notice documentation.
- Behavioral health carve-out routing: Many commercial plans including Aetna Behavioral Health and UnitedHealthcare Behavioral Health route addiction medicine claims through a separate managed behavioral health organization. Submitting addiction medicine claims to the medical carrier rather than the behavioral health carve-out entity creates systematic denials that can persist for months before the routing error is identified.
- MHPAEA parity enforcement for SUD treatment: When Humana or Cigna applies prior authorization, session limits, or step therapy requirements to addiction medicine services that are not applied to comparable medical conditions, a parity violation claim is valid. Building and submitting parity-based appeals requires comparative benefit documentation that most general billing services do not know how to gather.
- Medicaid managed care plan credentialing: Addiction medicine practices that treat a high-volume Medicaid population must be credentialed not just with the state Medicaid program but with each Medicaid managed care organization operating in the state. Missing credentialing with even one MCO results in claims being denied for all patients enrolled in that plan.
Key CPT Codes for Addiction Medicine Billing
- 99214: Established patient office visit, moderate complexity, the primary E/M code for monthly medication management visits in OBOT programs when documentation supports the complexity level
- 80307: Presumptive drug screen, by instrument chemistry analyzer, the standard qualitative urine drug screen code for point-of-care testing in addiction medicine settings
- G0480: Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers, 1-7 drug class(es), the Medicare code for definitive UDS panels
- 99408: Alcohol and/or substance abuse structured screening and brief intervention, 15 to 30 minutes, the SBIRT code applicable during primary care or addiction medicine visits
- H0020: Alcohol and/or drug services, methadone administration and/or service, a Medicaid HCPCS code used in opioid treatment program billing for daily methadone dispensing
Revenue Cycle Considerations for Addiction Medicine
Addiction medicine practices that manage OBOT programs generate a recurring monthly revenue base from medication management visits and UDS interpretations, which creates a more predictable revenue cycle than purely episodic-care specialties. However, Medicaid fee schedules, which are dominant in addiction medicine payer mix, pay substantially below commercial rates. A typical monthly OBOT visit pays $75 to $95 under many state Medicaid fee-for-service schedules versus $120 to $160 under commercial plans. Maximizing commercial payer revenue through correct coding and aggressive denial management is disproportionately important in addiction medicine because it offsets the lower Medicaid reimbursement that constitutes a large share of visit volume.
A/R days in addiction medicine practices typically run 32 to 50 days, with the longer tail driven by Medicaid managed care adjudication timelines and behavioral health carve-out routing corrections. Practices with high OBOT volume can improve their revenue cycle significantly by bundling UDS interpretation billing correctly rather than missing those charges, which often go unbilled in practices without a systematic charge capture process for laboratory interpretation services.
How My Medical Bill Solution Helps Addiction Medicine Practices
Somewhere in an addiction medicine practice tonight, a billing team is writing off a UDS interpretation charge because they are not sure how to code it, or a Medicaid claim is sitting denied because the routing went to the medical carrier instead of the behavioral health carve-out. My Medical Bill Solution builds the billing process from the ground up with addiction medicine-specific expertise: OBOT recurring revenue management, UDS coding and frequency tracking, behavioral health carve-out routing by payer, MHPAEA parity appeal support, and Medicaid MCO credentialing. Contact My Medical Bill Solution today for a free addiction medicine billing assessment.